Many people might be unaware that genes can be turned on and off, just like a light switch. Researchers at Duke University know this, and they are among several institutions receiving NIH funding to discover the nature of the "light switch" that makes it all possible. Duke University, in collaboration with the Center for Genomic and Computational Biology is one of five centers sharing $28.3 million in grants from the National Human Genome Research Institute to study mechanisms for gene regulation. According to a university press release the Duke University team, led by Tim Reddy, will receive $5.9 million to characterize how human lung epithelial cells respond to anti-inflammatory drugs called glucocorticoids.Read More
Science Market Update
Researchers at the University of California, Davis Cancer Center recently received $3 million in UC Davis life science funding from the National Cancer Institute, a part of the NIH. The project leader, Dr. De Vere White, targets his research to focus on prostate and bladder cancers. In addition Dr. De Vere has received continual NCI funding for this research since 1985.
Lab suppliers interested in taking advantage of life science marketing opportunities at universities with a wealth of life science research funding may be interested in the latest NIH funding awarded to Georgetown University. The NIH awarded Georgetown University $6.4 million this year for its department of internal medicine. The funding organization within the NIH was the National Center for Advancing Translational Sciences.
Tags: 2014, 2013, Georgetown University, Washington DC, Northeast, D.C., Geotwn, BioResearch Product Faire Event, NIH funding, NIH grant, NIH award, life science marketing events, life science marketing opportunities
Lab suppliers interested in meeting researchers with life science funding available to stock their labs in San Diego will want to take note of the latest life science funding news at the University of California, San Diego. Researchers at the University of California, San Diego received a $6 million grant from the NIH this year. The money will go towards the San Diego Clinical and Translational Research Institute and will fund the internal medicine department and the school of medicine.
Three researchers at Columbia University recently received NIH awards ranging from $1.9 million to $4 million in life science funding over the next five years. The prizes, part of the Health High Risk-High Reward program, were awarded to researchers whose work suggests highly original approaches to major challenges in biomedical research. The winners are Rafael Yuste, Ozgur Sahin, and Christine Ann Denny.
“Cardiac surgery has been a spectacularly innovative field of medicine,” says the abstract of a Mount Sinai School of Medicine grant proposal on the NIH RePORTER. “The introduction of major innovations and ongoing incremental change have extended survival and improved quality of life for many patients suffering from cardiac disease. A rapid pace of innovation requires a rigorous infrastructure for clinical evaluation that provides timely assessments of the value of new treatments.”
“Despite the clinical success of antiretroviral therapy (ART), more people contract human immunodeficiency virus (HIV) infection daily than initiate ART,” states the NIH RePORTER abstract for a new study receiving funding from the NIH. “The difficulties of lifelong ART - particularly in the developing world - make the eradication of HIV imperative. But clearance of a retroviral infection for patients on ART is a herculean task. While much is known about HIV persistence despite ART, many puzzles remain. New tools to address latent infection must replace the paradigms and models used to develop ART.”
Researchers at Stony Brook University recently received $1.2 million in life science funding from the NIH for a Sphingolipids in Cancer Biology and Therapy project led by Yusuf Awni Hannun. According to Stony Brook University, Dr. Hanuun is a renowned molecular biologist and physician-researcher interested in the molecular mechanisms of cancer. In 2012, he was appointed director of the Stony Brook Cancer Center, and he also serves as the Joel Kenny Professor of Medicine and Vice Dean for Cancer Medicine. The NIH RePORTER gives some background information on the project receiving NIH life science research funding:
The Duke Translational Medicine Institute at Duke University was recently awarded a five-year grant worth over $47 million by the NIH. The life science funding will go towards bringing biomedical research advances to patients. According to the Duke University news page, the Duke Translational Medicine Institute is Duke’s academic base for its clinical and translational research community where training in clinical and translational research is provided.